These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 10886255)

  • 41. Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2.
    Sobajima J; Ozaki S; Osakada F; Uesugi H; Shirakawa H; Yoshida M; Nakao K
    Clin Exp Immunol; 1997 Jan; 107(1):135-40. PubMed ID: 9010268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathophysiology of ANCA-associated vasculitides: are ANCA really pathogenic?
    Tervaert JW; Heeringa P
    Neth J Med; 2003 Dec; 61(12):404-7. PubMed ID: 15025415
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIa.
    Porges AJ; Redecha PB; Kimberly WT; Csernok E; Gross WL; Kimberly RP
    J Immunol; 1994 Aug; 153(3):1271-80. PubMed ID: 8027554
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of biologically active antineutrophil cytoplasmic antibodies by immunization with human apoptotic polymorphonuclear leukocytes.
    Rauova L; Gilburd B; Zurgil N; Blank M; Guegas LL; Brickman CM; Cebecauer L; Deutsch M; Wiik A; Shoenfeld Y
    Clin Immunol; 2002 Apr; 103(1):69-78. PubMed ID: 11987987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Complement system activation in ANCA vasculitis: A translational success story?
    Kallenberg CG; Heeringa P
    Mol Immunol; 2015 Nov; 68(1):53-6. PubMed ID: 26597208
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression profile of leukocyte genes activated by anti-neutrophil cytoplasmic autoantibodies (ANCA).
    Yang JJ; Preston GA; Alcorta DA; Waga I; Munger WE; Hogan SL; Sekura SB; Phillips BD; Thomas RP; Jennette JC; Falk RJ
    Kidney Int; 2002 Nov; 62(5):1638-49. PubMed ID: 12371964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IL-18 is upregulated in the kidney and primes neutrophil responsiveness in ANCA-associated vasculitis.
    Hewins P; Morgan MD; Holden N; Neil D; Williams JM; Savage CO; Harper L
    Kidney Int; 2006 Feb; 69(3):605-15. PubMed ID: 16514436
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathogenic role of anti-neutrophil cytoplasmic antibodies in vasculitis.
    Pankhurst T; Savage CO
    Curr Opin Pharmacol; 2006 Apr; 6(2):190-6. PubMed ID: 16483847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neutrophil extracellular trap formation is associated with autophagy-related signalling in ANCA-associated vasculitis.
    Tang S; Zhang Y; Yin SW; Gao XJ; Shi WW; Wang Y; Huang X; Wang L; Zou LY; Zhao JH; Huang YJ; Shan LY; Gounni AS; Wu YZ; Zhang JB
    Clin Exp Immunol; 2015 Jun; 180(3):408-18. PubMed ID: 25644394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autoantibodies to early endosome antigen (EEA1) produce a staining pattern resembling cytoplasmic anti-neutrophil cytoplasmic antibodies (C-ANCA).
    Selak S; Woodman RC; Fritzler MJ
    Clin Exp Immunol; 2000 Dec; 122(3):493-8. PubMed ID: 11122260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the regulation and functional consequences of p21ras activation in neutrophils by antineutrophil cytoplasm antibodies.
    Williams JM; Savage CO
    J Am Soc Nephrol; 2005 Jan; 16(1):90-6. PubMed ID: 15548565
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathogenesis of PR3-ANCA associated vasculitis.
    Kallenberg CG
    J Autoimmun; 2008; 30(1-2):29-36. PubMed ID: 18162369
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and pathophysiological significance of anti-neutrophil cytoplasmic autoantibodies in vasculitis syndromes.
    Wiik A
    Mod Rheumatol; 2009; 19(6):590-9. PubMed ID: 19730973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis after immunisation with bacterial proteins.
    Savige J; Nassis L; Cooper T; Paspaliaris B; Martinello P; MacGregor D
    Clin Exp Rheumatol; 2002; 20(6):783-9. PubMed ID: 12508769
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathogenesis of ANCA-associated vasculitis: An update.
    Jarrot PA; Kaplanski G
    Autoimmun Rev; 2016 Jul; 15(7):704-13. PubMed ID: 26970490
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process.
    Holden NJ; Williams JM; Morgan MD; Challa A; Gordon J; Pepper RJ; Salama AD; Harper L; Savage CO
    Ann Rheum Dis; 2011 Dec; 70(12):2229-33. PubMed ID: 21859691
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Autoantibodies to neutrophil granule proteins: pathogenic potential in vasculitis?
    Locke IC; Cambridge G
    Br J Biomed Sci; 1996 Dec; 53(4):302-16. PubMed ID: 9069109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.